These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 26292066

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Screening of flavonoids as candidate antibiotics against Enterococcus faecalis.
    Jeong KW, Lee JY, Kang DI, Lee JU, Shin SY, Kim Y.
    J Nat Prod; 2009 Apr; 72(4):719-24. PubMed ID: 19236029
    [Abstract] [Full Text] [Related]

  • 6. Acyl carrier protein (ACP) inhibition and other differences between beta-ketoacyl synthase (KAS) I and II.
    Arnvig Mcguire K, McGuire JN, von Wettstein-Knowles P.
    Biochem Soc Trans; 2000 Dec; 28(6):607-10. PubMed ID: 11171141
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure of the complex between the antibiotic cerulenin and its target, beta-ketoacyl-acyl carrier protein synthase.
    Moche M, Schneider G, Edwards P, Dehesh K, Lindqvist Y.
    J Biol Chem; 1999 Mar 05; 274(10):6031-4. PubMed ID: 10037680
    [Abstract] [Full Text] [Related]

  • 9. Novel inhibitors of the condensing enzymes of the type II fatty acid synthase of pea (Pisum sativum).
    Jones AL, Herbert D, Rutter AJ, Dancer JE, Harwood JL.
    Biochem J; 2000 Apr 01; 347 Pt 1(Pt 1):205-9. PubMed ID: 10727420
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structure of the human beta-ketoacyl [ACP] synthase from the mitochondrial type II fatty acid synthase.
    Christensen CE, Kragelund BB, von Wettstein-Knowles P, Henriksen A.
    Protein Sci; 2007 Feb 01; 16(2):261-72. PubMed ID: 17242430
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
    Li HQ, Shi L, Li QS, Liu PG, Luo Y, Zhao J, Zhu HL.
    Bioorg Med Chem; 2009 Sep 01; 17(17):6264-9. PubMed ID: 19664929
    [Abstract] [Full Text] [Related]

  • 16. X-ray crystal structure of Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase II (mtKasB).
    Sridharan S, Wang L, Brown AK, Dover LG, Kremer L, Besra GS, Sacchettini JC.
    J Mol Biol; 2007 Feb 16; 366(2):469-80. PubMed ID: 17174327
    [Abstract] [Full Text] [Related]

  • 17. Homology modelling of 3-oxoacyl-acyl carrier protein synthase II from Mycobacterium tuberculosis H37Rv and molecular docking for exploration of drugs.
    Singh V, Somvanshi P.
    J Mol Model; 2009 May 16; 15(5):453-60. PubMed ID: 19083031
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
    Lv PC, Sun J, Luo Y, Yang Y, Zhu HL.
    Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4657-60. PubMed ID: 20594840
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism.
    Price AC, Choi KH, Heath RJ, Li Z, White SW, Rock CO.
    J Biol Chem; 2001 Mar 02; 276(9):6551-9. PubMed ID: 11050088
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.